Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

Similar articles for PubMed (Select 20050931)

1.

Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.

Fung V, Mangione CM, Huang J, Turk N, Quiter ES, Schmittdiel JA, Hsu J.

Health Serv Res. 2010 Apr;45(2):355-75. doi: 10.1111/j.1475-6773.2009.01071.x. Epub 2009 Dec 30.

2.

Effects of Medicare Part D coverage gap on medication adherence.

Zhang Y, Baik SH, Lave JR.

Am J Manag Care. 2013 Jun 1;19(6):e214-24.

3.

Medicare Part D coverage gap and diabetes beneficiaries.

Schmittdiel JA, Ettner SL, Fung V, Huang J, Turk N, Quiter ES, Swain BE, Hsu JT, Mangione CM.

Am J Manag Care. 2009 Mar;15(3):189-93.

4.

Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.

Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC.

J Manag Care Spec Pharm. 2014 Aug;20(8):862-76.

5.

Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan.

Nair KV, Frech-Tamas F, Jan S, Wolfe P, Allen RR, Saseen JJ.

J Health Care Finance. 2011 Winter;38(2):38-53.

PMID:
22372031
6.

Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.

Hsu J, Fung V, Price M, Huang J, Brand R, Hui R, Fireman B, Newhouse JP.

JAMA. 2008 Apr 23;299(16):1929-36. doi: 10.1001/jama.299.16.1929.

PMID:
18430912
7.

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.

Goedken AM, Urmie JM, Farris KB, Doucette WR.

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

PMID:
20511109
8.

Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study.

Duru OK, Mangione CM, Hsu J, Steers WN, Quiter E, Turk N, Ettner SL, Schmittdiel JA, Tseng CW.

J Am Geriatr Soc. 2010 May;58(5):822-8. doi: 10.1111/j.1532-5415.2010.02813.x. Epub 2010 Apr 6.

9.

Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.

Conwell LJ, Esposito D, Garavaglia S, Meadows ES, Colby M, Herrera V, Goldfarb S, Ball D, Marciniak M.

Am J Geriatr Pharmacother. 2011 Aug;9(4):241-9. doi: 10.1016/j.amjopharm.2011.04.009. Epub 2011 May 26.

PMID:
21616722
10.

The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure.

Baik SH, Rollman BL, Reynolds CF 3rd, Lave JR, Smith KJ, Zhang Y.

J Ment Health Policy Econ. 2012 Sep;15(3):105-18.

11.

Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap.

Polinski JM, Shrank WH, Huskamp HA, Glynn RJ, Liberman JN, Schneeweiss S.

PLoS Med. 2011 Aug;8(8):e1001075. doi: 10.1371/journal.pmed.1001075. Epub 2011 Aug 16. Erratum in: PLoS Med. 2014 Aug;11(8):e1001716.

12.

Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.

Gross DJ, Alecxih L, Gibson MJ, Corea J, Caplan C, Brangan N.

Health Serv Res. 1999 Apr;34(1 Pt 2):241-54.

13.

Beneficiaries with cardiovascular disease and thePart D coverage gap.

Polinski JM, Shrank WH, Glynn RJ, Huskamp HA, Roebuck MC, Schneeweiss S.

Circ Cardiovasc Qual Outcomes. 2012 May;5(3):387-95. doi: 10.1161/CIRCOUTCOMES.111.964866. Epub 2012 Apr 17.

14.

Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.

Safran DG, Strollo MK, Guterman S, Li A, Rogers WH, Neuman P.

J Gen Intern Med. 2010 Jan;25(1):10-7. doi: 10.1007/s11606-009-1134-2. Epub 2009 Oct 31.

15.

Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage.

McWilliams JM, Zaslavsky AM, Huskamp HA.

JAMA. 2011 Jul 27;306(4):402-9. doi: 10.1001/jama.2011.1026.

PMID:
21791689
16.

The effect of Medicare Part D on drug and medical spending.

Zhang Y, Donohue JM, Lave JR, O'Donnell G, Newhouse JP.

N Engl J Med. 2009 Jul 2;361(1):52-61. doi: 10.1056/NEJMsa0807998.

17.

Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007.

Briesacher BA, Zhao Y, Madden JM, Zhang F, Adams AS, Tjia J, Ross-Degnan D, Gurwitz JH, Soumerai SB.

Med Care. 2011 Sep;49(9):834-41. doi: 10.1097/MLR.0b013e3182162afb.

18.

Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?

Mott DA, Thorpe JM, Thorpe CT, Kreling DH, Gadkari AS.

Res Social Adm Pharm. 2010 Jun;6(2):90-9. doi: 10.1016/j.sapharm.2010.02.004.

19.

Patient-provider communication regarding drug costs in Medicare Part D beneficiaries with diabetes: a TRIAD Study.

Schmittdiel JA, Steers N, Duru OK, Ettner SL, Brown AF, Fung V, Hsu J, Quiter E, Tseng CW, Mangione CM.

BMC Health Serv Res. 2010 Jun 14;10:164. doi: 10.1186/1472-6963-10-164.

20.

Digesting the doughnut hole.

Joyce GF, Zissimopoulos J, Goldman DP.

J Health Econ. 2013 Dec;32(6):1345-55. doi: 10.1016/j.jhealeco.2013.04.007. Epub 2013 May 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk